Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2637-2641

  Cvejic, Dubravka ^a   Savin, Svetlana ^a   Paunovic, Ivan ^b   Tatic, Svetislav ^c   Havelka, Marija ^c   Sinadinovic, Jovan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Galectin 3; Human thyroid; Immunohistochemistry; Neoplastic transformation

Indexed keywords

GALECTIN 3; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROID CANCER; THYROID FOLLICULAR CARCINOMA;

EID: 0031810578     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Li Volsi VA. Surgical pathology of the thyroid. In: Major Problems in Pathology, Vol. 22, (Bennington JL, ed ). Philadelphia, WB Saunders, 1990, pp136-172.
2. Murray D: The thyroid gland. In:Functional Endocrine Pathology (Kovacs K and Asa L, eds). Blackwell Scientific Publications, Boston, 1991, pp 293-374.
3. Rosai J, Carcangiu ML and DeLellis RA: Tumors of the Thyroid Gland. Atlas of Tumor Pathology. 3rd Series Fascicle 5. Washington D.C. Armed Forces Institute of Pathology, 1993.
4. Akslen LA: Thyroid cancer-Some aspects of epidemiology and etiological factors, pathological features and tumor biology. Int J Oncol 4: 931-942, 1994.
5. Mizukami Y, Michigishi T, Nonomura A, Noguchi M and Nakamura H: Thyroid carcinoma: clinical, pathologic correlations. Crit Rev Oncol / Hematol 18: 67-102, 1995.
6. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, et al: Galectins: a family of animal ß-galactoside binding lectins. Cell 76: 597-598, 1994.
7. Barondes SH, Cooper DNW, Gitt MA and Leffler H: Galectins: structure and function of a large family of animal lectins. J Biol Chem 269: 20807-20810, 1994.
8. Zhou Q and Cummings RD: Animal lectins: a distinct group of carbohydrate-binding proteins involved in cell adhesion, molecular recognition and development. In: Cell Surface Carbohydrates and Cell Development. ( Fukuda M, ed ). Boca Raton, FL, CRC Press, 1992, pp 99-126.
9. Lotan R: ß-galactoside - binding vertebrate lectins: synthesis, molecular biology, function. In: Glycoconjugates: Composition, Structure and Function ( Allen H and Kisalius E, eds ). New York, Marcel Dekker, 1992, pp 635-671.
10. Drickamer K and Taylor ME: Biology of animal lectins. Annu Rev Cell Biol 9: 237-264, 1993.
11. Ohannesian DW and Lotan R: Galectins in tumor cellsMn: Glycosciences, Status and Perspectives (Gabius HJ and Gabius S, eds). Chapman and Hall GMBH, Weinheim, 1997, pp 459-469.
12. Lee EC, Woo HJ, Korzelius CA, Steele GB and Mercurio AM: Carbohydrate - binding protein 35 is the major cell surface laminin -binding protein in colon carcinoma. Arch Surg 126: 1496-1502, 1991.
13. Irimura T, Matsushita Y, Sutton RC, Carralero ED, Ohannesian DW, Cleary KR et al: Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 51: 387-393, 1991.
14. Castronovo V, Campo E, van den Brule FA, Claysmith AP, Cioce V, Liu FT, et al: Inverse modulation of steady-state messenger RNA levels of two non - integrin laminin binding proteins in human colon carcinoma. J Natl Cancer Inst 84: 1161-1169, 1992.
15. Lotz M, Andrews CV, Korzelius CA, Lee EC, Steele GD, Clarke A, et al: Decreased expression of Mac-2 (carbohydrate-binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90: 3466-3470, 1993.
16. Shoeppner HL, Raz A, Ho SB and Bresalier RS: Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818-2826, 1995.
17. Nangia - Makker P, Thompson E, Hogan C, Ochieng J and Raz A: Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 7: 1079-1087, 1995.
18. Castronovo V, van den Brule FA, Jackers P, Clausse N, Liu FT, Gillet C. et al: Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179: 43-48, 1 996.
19. Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D and Tahara E: Expression of a 31 - kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int J Cancer 56: 474-480, 1994.
20. Bresalier RS, Yan PS, Byrd JC, Lotan R and Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80: 776-787, 1997.
21. Xu X-C, El - Naggar AK and Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147: 815-822, 1995.
22. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, et al: Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181: 80-86, 1997.
23. Hedinger C, Williams ED and Sobin LH. Histological typing of thyroid tumours. 2nd ed. In: International histological classification of tumours. World Health Organization. Geneva, Springer - Verlag, 1988.
24. Hedinger C, Williams ED and Sobin LH: The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 65: 908-911, 1989.
25. Ho MK and Springer TA: Mac-2, a novel 32, 000 M, mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128: 1221-1228, 1982.
26. Cherayil BJ, Weiner SJ and Pillai S: The Mac-2 antigen is a galactose-specific lectin that binds IgE. J Exp Med 170: 1959-1972, 1989.
27. Huflejt ME, Turck CW, Lindstedt R, Barondes SH and Leffler H: L-29, a soluble lactose binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase 1. J Biol Chem 268: 26712-26718, 1993.
28. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
29. LiVolsi VA: Papillary neoplasms of the thyroid: pathologic and prognostic features. Am J Clin Pathol 97: 426-434, 1992.
30. Wang JL, Werner EA, Laing JG and Patterson RJ: Nuclear and cytoplasmic localization of a lectin-ribonucleoprotein complex. Biochem Soc Transact 20: 269-274, 1992.
31. Wang L, Inohara H, Pienta KJ and Raz A. Galectin-3 is a nuclear matrix protein which binds RNA. Biochem Biophys Res Commun 217: 292-303, 1995.
32. Woo HJ, Shaw LM, Messier JM and Mercurio AM: The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J Biol Chem 265: 7097-7099, 1990.
33. Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius HJ, et al: Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55: 2191-2199, 1995.
34. Goletz S, Hanisch F-G and Karsten U. Novel α-GalNAc containing glycans on cytokeratins are recognized in vitro by galectins with type II carbohydrate recognition domains. J Cell Science 110: 1585 -1596, 1997.